Recent Posts
- New partners to develop universal gene therapy for hemophilia
- ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
- GeneVentiv to Attend BIO CEO & Investor Conference
- GeneVentiv to Attend Biotech Showcase
- GeneVentiv Therapeutics to Attend BIO Europe Fall 2023
Recent Comments